Skip to content
healthcare.dev

ADAKVEO

NDC 0078-0883, crizanlizumab, injection, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0883
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761128
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0883 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CRIZANLIZUMAB10 mg/mL

Pharmacologic classes

P-Selectin Blockers [MoA]; Selectin Blocker [EPC]

Package NDCNDC-11Package
0078-0883-610007808836110 mL in 1 VIAL, GLASS (0078-0883-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0883

Use it

Look up 0078-0883 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0883 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0883. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.